FLICE-like inhibitory protein blocks transforming growth factor beta 1-induced caspase activation and apoptosis in

Kent L Nastiuk1, Kiwon Yoo, Karen Lo

  • 1Department of Pathology and Laboratory Medicine, School of Medicine, University of California Irvine, Medical Sciences I D450, Irvine, CA 92697-4800, USA.

Insights

FLICE-like inhibitory protein (FLIP) reduction triggers prostate cancer cell death. Restoring FLIP levels can prevent apoptosis, offering a potential therapeutic strategy for prostate cancer.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Androgen withdrawal causes prostate cancer regression but leads to androgen independence and metastasis.
  • Understanding androgen withdrawal-induced apoptosis is crucial for developing new prostate cancer therapies.
  • FLICE-like inhibitory protein (FLIP) is an apical caspase inhibitor whose expression decreases during castration-induced apoptosis in rats.

Purpose of the Study:

  • To investigate the functional role of FLIP in inhibiting prostate epithelial cell apoptosis.
  • To determine if FLIP levels influence the sensitivity of prostate cancer cells to apoptosis induced by transforming growth factor beta1 (TGFbeta1).

Main Methods:

  • Utilized the rat prostate epithelial cell line NRP-152, which undergoes apoptosis upon TGFbeta1 treatment, mimicking androgen withdrawal.
  • Assessed FLIP levels, caspase activity, and cell death following TGFbeta1 treatment.
  • Employed small interfering RNA (siRNA) to knock down FLIP expression and created stable cell lines with constitutively expressed FLIP.
  • Investigated the effects of insulin and receptor-Fc fusion proteins (Fas-Fc, sTNFRII-Fc, DR5-Fc) on TGFbeta1-induced apoptosis.

Main Results:

  • FLIP levels decreased with TGFbeta1 treatment, correlating with increased apoptosis.
  • Caspase inhibitor crmA blocked TGFbeta1-induced apoptosis, suggesting caspase-8 involvement.
  • FLIP knockdown enhanced TGFbeta1-induced cell death, while stable FLIP expression rendered cells resistant to apoptosis.
  • TGFbeta1-induced caspase-3 activity was inversely proportional to FLIP levels.
  • Insulin increased FLIP and inhibited TGFbeta1-induced death in a FLIP-dependent manner.
  • TGFbeta1 stimulation increased tumor necrosis factor mRNA, indicating a potential role for TNF in this model.

Conclusions:

  • FLIP plays a critical role in preventing prostate epithelial cell apoptosis induced by TGFbeta1.
  • FLIP levels are a key determinant of cell sensitivity to apoptosis, suggesting FLIP as a therapeutic target.
  • While caspase-8 and tumor necrosis factor may be involved, FLIP might also inhibit other unknown caspase-dependent apoptotic mediators.

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.